Jaguar Health, Inc. (JAGX) has a negative trailing P/E of 0.0, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. Trailing earnings yield is -6,123.67%.
Criteria proven by this page:
Overall SharesGrow Score: 55/100 with 3/7 criteria passed.
| Year | P/E (TTM) | PEG Ratio | P/B Ratio | P/S Ratio | Dividend Yield |
|---|---|---|---|---|---|
| 2016 | 0.0 | 0.00 | 0.00 | 0.00 | - |
| 2017 | 0.0 | 0.00 | 0.00 | 0.00 | - |
| 2018 | 0.0 | 0.00 | 0.00 | 0.00 | - |
| 2019 | 0.0 | 0.00 | 0.00 | 0.00 | - |
| 2020 | 0.0 | 0.00 | 0.00 | 0.00 | - |
| 2021 | 0.0 | 0.00 | 0.02 | 0.05 | - |
| 2022 | 0.0 | 0.00 | -0.06 | 0.00 | - |
| 2023 | 0.0 | 0.00 | 0.24 | 0.12 | - |
| 2024 | -0.2 | 0.00 | 1.02 | 0.64 | - |
| 2025 | 0.0 | 0.00 | -0.13 | 0.19 | - |
| Year | EPS (Diluted) | Revenue | Net Income | Net Margin |
|---|---|---|---|---|
| 2015 | $-169,803,000,000,000.00 | $258.38K | $-16.29M | -6305.2% |
| 2016 | $-88,496,300,000,000.00 | $141.52K | $-14.73M | -10410.9% |
| 2017 | $-9,658,970,000,000.00 | $4.36M | $-21.97M | -503.7% |
| 2018 | $-366,353,000,000.00 | $4.42M | $-32.15M | -727.9% |
| 2019 | $-589,407,000.00 | $5.78M | $-38.54M | -667.3% |
| 2020 | $-72,299,200.00 | $9.39M | $-36.79M | -392% |
| 2021 | $-11,370,400.00 | $4.34M | $-60.25M | -1389.9% |
| 2022 | $-4,070,250.00 | $11.96M | $-47.45M | -396.9% |
| 2023 | $-2,685.00 | $9.76M | $-41.3M | -423.1% |
| 2024 | $-130.69 | $11.69M | $-38.49M | -329.3% |
| Year | EPS (Avg) | EPS Range | Revenue (Avg) | Revenue Range | Analysts |
|---|---|---|---|---|---|
| 2026 | $-0.12 | $-0.12 – $-0.12 | $2.46M | $2.46M – $2.46M | 1 |
| 2027 | $-0.27 | $-0.27 – $-0.27 | $4.11M | $4.11M – $4.11M | 1 |
